Skip to main content
American heart journal
Reducing ethnic and racial disparities by improving undertreatment, control, and engagement in blood pressure management with health information technology (REDUCE-BP) hybrid effectiveness-implementation pragmatic trial: Rationale and design.
Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction.
Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry.
Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry.
Corrigendum to "Assessing cardiac safety in oncology drug development" [Am Heart J 214 (2019) 125-133].
Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy.
Financial strain and ideal cardiovascular health in middle-aged and older women: Data from the Women's health study.
Assessing cardiac safety in oncology drug development.
Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.
Design and rationale of a randomized noninferiority trial to evaluate the SurVeil drug-coated balloon in subjects with stenotic lesions of the femoropopliteal artery - the TRANSCEND study.
